Pharvaris Bv Stock Alpha and Beta Analysis

PHVS Stock  USD 21.90  0.46  2.06%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pharvaris BV. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pharvaris over a specified time horizon. Remember, high Pharvaris' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pharvaris' market risk premium analysis include:
Beta
1.51
Alpha
0.18
Risk
4.02
Sharpe Ratio
0.11
Expected Return
0.43
Please note that although Pharvaris alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Pharvaris did 0.18  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Pharvaris BV stock's relative risk over its benchmark. Pharvaris BV has a beta of 1.51  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharvaris will likely underperform. At this time, Pharvaris' Book Value Per Share is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 10.50 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (6.32) in 2024.

Enterprise Value

522.67 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Pharvaris Backtesting, Pharvaris Valuation, Pharvaris Correlation, Pharvaris Hype Analysis, Pharvaris Volatility, Pharvaris History and analyze Pharvaris Performance.

Pharvaris Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pharvaris market risk premium is the additional return an investor will receive from holding Pharvaris long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharvaris. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pharvaris' performance over market.
α0.18   β1.51

Pharvaris expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pharvaris' Buy-and-hold return. Our buy-and-hold chart shows how Pharvaris performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Pharvaris Market Price Analysis

Market price analysis indicators help investors to evaluate how Pharvaris stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharvaris shares will generate the highest return on investment. By understating and applying Pharvaris stock market price indicators, traders can identify Pharvaris position entry and exit signals to maximize returns.

Pharvaris Return and Market Media

The median price of Pharvaris for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 20.56 with a coefficient of variation of 10.04. The daily time series for the period is distributed with a sample standard deviation of 2.07, arithmetic mean of 20.63, and mean deviation of 1.68. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Short Interest in Pharvaris Expands By .5
09/17/2024
2
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop
10/03/2024
3
Pharvaris Stock Price Down 7.9 percent Whats Next
11/07/2024
4
Pharvaris reports Q3 results
11/14/2024

About Pharvaris Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pharvaris or other stocks. Alpha measures the amount that position in Pharvaris BV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
PB Ratio1.882.362.542.41
Capex To Depreciation1.680.810.350.33

Pharvaris Upcoming Company Events

As portrayed in its financial statements, the presentation of Pharvaris' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharvaris' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pharvaris' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pharvaris. Please utilize our Beneish M Score to check the likelihood of Pharvaris' management manipulating its earnings.
3rd of April 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Pharvaris

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.